Publicly available transcriptomic data revealed that TLR8, but not TLR7, is highly expressed in MDS samples at levels comparable to healthy bone marrow, while expression in AML is generally reduced and heterogeneous. The gene discussed is TLR8; the disease is myelodysplastic syndrome.